H Ben-Pazi1, P Browne2,3, P Chan4, E Cubo5, M Guttman6, A Hassan7, J Hatcher-Martin8, Z Mari9, E Moukheiber10, N U Okubadejo11, A Shalash12. 1. Neuropediatric unit, Shaare Zedek Medical Center, Jerusalem, Israel. 2. Neurology Department, University Hospital Galway, Newcastle Road, Galway, Ireland. 3. School of Medicine, National University of Ireland Galway, Galway, Ireland. 4. Department of Neurobiology, Neurology and Geriatrics, Xuanwu Hospital of Capital Medical University Beijing, Beijing, China. 5. Neurology Department, University Hospital, Burgos, Spain. mcubo@saludcastillayleon.es. 6. University of Toronto, Toronto, ON, Canada. 7. Department of Neurology, Mayo Clinic, Rochester, MN, USA. 8. Movement Disorders Program, Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA. 9. Parkinson's Disease and Movement Disorders Program, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, USA. 10. Department of Neurology, Johns Hopkins Medicine, Baltimore, MD, USA. 11. Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos State, Nigeria. 12. Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Abstract
PURPOSE OF REVIEW: Advances in technology have expanded telemedicine opportunities covering medical practice, research, and education. This is of particular importance in movement disorders (MDs), where the combination of disease progression, mobility limitations, and the sparse distribution of MD specialists increase the difficulty to access. In this review, we discuss the prospects, challenges, and strategies for telemedicine in MDs. RECENT FINDINGS: Telemedicine for MDs has been mainly evaluated in Parkinson's disease (PD) and compared to in-office care is cost-effective with similar clinical care, despite the barriers to engagement. However, particular groups including pediatric patients, rare MDs, and the use of telemedicine in underserved areas need further research. Interdisciplinary telemedicine and tele-education for MDs are feasible, provide similar care, and reduce travel costs and travel time compared to in-person visits. These benefits have been mainly demonstrated for PD but serve as a model for further validation in other movement disorders.
PURPOSE OF REVIEW: Advances in technology have expanded telemedicine opportunities covering medical practice, research, and education. This is of particular importance in movement disorders (MDs), where the combination of disease progression, mobility limitations, and the sparse distribution of MD specialists increase the difficulty to access. In this review, we discuss the prospects, challenges, and strategies for telemedicine in MDs. RECENT FINDINGS: Telemedicine for MDs has been mainly evaluated in Parkinson's disease (PD) and compared to in-office care is cost-effective with similar clinical care, despite the barriers to engagement. However, particular groups including pediatric patients, rare MDs, and the use of telemedicine in underserved areas need further research. Interdisciplinary telemedicine and tele-education for MDs are feasible, provide similar care, and reduce travel costs and travel time compared to in-person visits. These benefits have been mainly demonstrated for PD but serve as a model for further validation in other movement disorders.
Entities:
Keywords:
Movement disorders; Tele-education; Telehealth; Telemedicine
Authors: Esther Cubo; Jacques Doumbe; Emiliano López; Guadalupe A Lopez; Emilia Gatto; Gabriel Persi; Mark Guttman Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2017-10-19
Authors: Brian M Bot; Christine Suver; Elias Chaibub Neto; Michael Kellen; Arno Klein; Christopher Bare; Megan Doerr; Abhishek Pratap; John Wilbanks; E Ray Dorsey; Stephen H Friend; Andrew D Trister Journal: Sci Data Date: 2016-03-03 Impact factor: 6.444
Authors: Stella M Papa; Patrik Brundin; Victor S C Fung; Un Jung Kang; David J Burn; Carlo Colosimo; Han-Lin Chiang; Roy N Alcalay; Claudia Trenkwalder Journal: Mov Disord Date: 2020-04-16 Impact factor: 10.338
Authors: Stella M Papa; Patrik Brundin; Victor S C Fung; Un Jung Kang; David J Burn; Carlo Colosimo; Han-Lin Chiang; Roy N Alcalay; Claudia Trenkwalder Journal: Mov Disord Clin Pract Date: 2020-04-16
Authors: Lorena Rosa S Almeida; Maria Elisa Pimentel Piemonte; Helen M Cavalcanti; Colleen G Canning; Serene S Paul Journal: Mov Disord Clin Pract Date: 2021-03-11
Authors: Diane Stephenson; Robert Alexander; Varun Aggarwal; Reham Badawy; Lisa Bain; Roopal Bhatnagar; Bastiaan R Bloem; Babak Boroojerdi; Jackson Burton; Jesse M Cedarbaum; Josh Cosman; David T Dexter; Marissa Dockendorf; E Ray Dorsey; Ariel V Dowling; Luc J W Evers; Katherine Fisher; Mark Frasier; Luis Garcia-Gancedo; Jennifer C Goldsack; Derek Hill; Janice Hitchcock; Michele T Hu; Michael P Lawton; Susan J Lee; Michael Lindemann; Ken Marek; Nitin Mehrotra; Marjan J Meinders; Michael Minchik; Lauren Oliva; Klaus Romero; George Roussos; Robert Rubens; Sakshi Sadar; Joseph Scheeren; Eiichi Sengoku; Tanya Simuni; Glenn Stebbins; Kirsten I Taylor; Beatrice Yang; Neta Zach Journal: Digit Biomark Date: 2020-11-26
Authors: Christopher G Tarolli; Grace A Zimmerman; Steven Goldenthal; Blake Feldman; Sarah Berk; Bernadette Siddiqi; Catherine M Kopil; Sohini Chowdhury; Kevin M Biglan; E Ray Dorsey; Jamie L Adams Journal: Neurol Clin Pract Date: 2020-02